These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8890678)

  • 21. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA; Koszycki D; Bradwejn J
    Depress Anxiety; 2004; 20(2):51-8. PubMed ID: 15390214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 2000 Jun; 20(3):338-46. PubMed ID: 10831021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stressful reactions and panic attacks induced by flumazenil in chronic benzodiazepine users.
    Bernik MA; Gorenstein C; Vieira Filho AH
    J Psychopharmacol; 1998; 12(2):146-50. PubMed ID: 9694026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alexithymia and anxiety sensitivity in panic disorder and obsessive-compulsive disorder.
    Zeitlin SB; McNally RJ
    Am J Psychiatry; 1993 Apr; 150(4):658-60. PubMed ID: 8031330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The assessment and treatment of refractory anxiety.
    Hollander E; Cohen LJ
    J Clin Psychiatry; 1994 Feb; 55 Suppl():27-31. PubMed ID: 7915712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inositol treatment of obsessive-compulsive disorder.
    Fux M; Levine J; Aviv A; Belmaker RH
    Am J Psychiatry; 1996 Sep; 153(9):1219-21. PubMed ID: 8780431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
    Modigh K; Westberg P; Eriksson E
    J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obsessive-compulsive symptoms in panic disorder.
    Mellman TA; Uhde TW
    Am J Psychiatry; 1987 Dec; 144(12):1573-6. PubMed ID: 3688281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA; Bullock T; Fineberg N
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract]   [Full Text] [Related]  

  • 33. Panic disorder and obsessive compulsive disorder in a hyperventilation challenge test.
    Nardi AE; Valença AM; Nascimento I; Zin WA
    J Affect Disord; 2002 Apr; 68(2-3):335-40. PubMed ID: 12063161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new benzodiazepine screened in a parallel double-blind test].
    Lens F
    Acta Psychiatr Belg; 1974 May; 74(3):327-37. PubMed ID: 4156150
    [No Abstract]   [Full Text] [Related]  

  • 35. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis.
    van den Heuvel OA; Veltman DJ; Groenewegen HJ; Witter MP; Merkelbach J; Cath DC; van Balkom AJ; van Oppen P; van Dyck R
    Arch Gen Psychiatry; 2005 Aug; 62(8):922-33. PubMed ID: 16061770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
    Donovan MR; Glue P; Kolluri S; Emir B
    J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzodiazepine pharmacodynamics: utility of eye movement measures.
    Roy-Byrne PP; Cowley DS; Radant A; Hommer D; Greenblatt DJ
    Psychopharmacology (Berl); 1993; 110(1-2):85-91. PubMed ID: 7870903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The changes of thyroid hormone during pharmacological treatment of panic disorder patients.
    Balon R; Pohl R; Yeragani VK; Ramesh C; Glitz DA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):595-600. PubMed ID: 1956988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Let's talk facts about anxiety disorders.
    American Psychiatric Association
    J Okla State Med Assoc; 2008 Dec; 101(12):347-50. PubMed ID: 19177997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.